Insulin sensitivity in Type 2 diabetes: univariate and multivariate techniques to derive estimates of insulin sensitivity from the insulin modified intravenous glucose tolerance test (FSIGT). - Guenther H. Mehring; Philip A. Coates; Patrick C. Brunel; Stephen D. Luzio; David R. Owens (Comput. Methods Programs Biomed., 2002)

Portal Technologies for Patient-centred Integrated Care. - Ali Shaikh Ali; Omer F. Rana; Alex R. Hardisty; Mahesh Subramanian; Stephen D. Luzio; David R. Owens; Edward C. Conley (ECEH, 2007)

Alchemist Multimodal Workflows for Diabetic Retinopathy Research, Disease Prevention and Investigational Drug Discovery. - Adina Riposan; Ian J. Taylor; David R. Owens; Omer F. Rana; Edward C. Conley (HealthGrid, 2007)

Novel Sensor Technology Integration for Outcome-Based Risk Analysis in Diabetes. - Mahesh Subramanian; Edward C. Conley; Omer F. Rana; Alex R. Hardisty; Ali Shaikh Ali; Stephen D. Luzio; David R. Owens; Steve Wright; Tim Donovan; Bharat V. Bedi; Dave Conway-Jones; David Vyvyan; et al. (HEALTHINF (2), 2008)

The TRIACS analytical workflows platform for distributed clinical decision support. - Adina Riposan; Ian J. Taylor; Omer F. Rana; David R. Owens; Edward C. Conley (CBMS, 2009)

Improving Disease Early Detection and Prevention by Multiplex Longitudinal Outcomes Marker Modeling. - Edward C. Conley; David R. Owens (eTELEMED, 2009)

Superimposition of eye fundus images for longitudinal analysis from large public health databases. - Guillaume Noyel; Rebecca Thomas; Gavin Bhakta; Andrew Crowder; David Owens 001; Peter Boyle (CoRR, 2016)

Registration Of Retinal Images From Public Health By Minimising An Error Between Vessels Using An Affine Model With Radial Distortions. - Guillaume Noyel; Rebecca Thomas; Simon Iles; Gavin Bhakta; Andrew Crowder; David R. Owens; Peter Boyle (ISBI, 2019)

Enhancing stroke risk and prognostic timeframe assessment with deep learning and a broad range of retinal biomarkers. - Shvat Messica; Dan Presil; Yaacov Hoch; Tsvi Lev; Aviel Hadad; Or Katz; David R. Owens (Artif. Intell. Medicine, 2024)